Opko Health Inc (OPK) Stock Price, Quote & News

Company Profile

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 305 575 4100

Website: www.opko.com

Address:

4400 Biscayne Boulevard, Miami, United States

tymtested Feb. 2 at 10:24 PM

$OPK The huge volume is a mystery.

1 · Reply

Mike18181 Feb. 2 at 8:57 PM

$OPK ( FCF) Free Cashflow at Opko is why you have 1.26, and there dumping stock. Do not be " fooled" by asset sales and 432 million in cash. They admit the operation continue to lose money. This is planned by Frost to drive down the stock. Its going private with No winners IMO !

0 · Reply

Mike18181 Feb. 2 at 7:22 PM

$OPK Not undervalued ! Its Undermanaged!

0 · Reply

allybaba40t Feb. 1 at 6:40 PM

$OPK and PLTR Have The Same Equity Summary Score, [6.1]... UNBELIEVABLE!!!

1 · Reply

Mike18181 Feb. 1 at 2:55 PM

$OPK Zehorney (Opko President) will broadcast upcoming Q1 2026 shareholder address from a " gas station mens room " as he boards another plane. Nice job Pal ! Were still losing Money Sweety !@

0 · Reply

Sierradude Jan. 30 at 5:21 PM

$OPK Will be interesting to see what the old coot does with his shares when he croaks....

1 · Reply

Zerrat Jan. 30 at 3:48 PM

$OPK stock buy back and year low. Such a joke

0 · Reply

Mike18181 Jan. 30 at 12:43 AM

$OPK Plenty of cash on hand , and this stock is an absolute bargin.🤡🛌🤡 🛌 🤡 🛌 🤡 is poised to to rocket up to a price of 1.35 this year ! Buy rating from many Blind brokers

0 · Reply

magadog Jan. 29 at 8:41 AM

$OPK newcomers see this as too cheap until the Frost factor kicks in.. He loves penny stocks so much he turned he whole company into a penny stock

0 · Reply

Biotechguy21 Jan. 28 at 11:42 PM

$OPK ceo in jail yet? ?????

1 · Reply

OPKO Health: Deeply Mispriced Ahead Of Major Catalysts

Jan 15, 2026, 5:45 AM EST - 19 days ago

OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 6, 2026, 4:11 PM EST - 4 weeks ago

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Nov 19, 2025, 4:05 PM EST - 2 months ago

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

Oct 29, 2025, 9:36 PM EDT - 3 months ago

OPKO Health, Inc. (OPK) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 4:05 PM EDT - 3 months ago

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

Oct 22, 2025, 4:05 PM EDT - 3 months ago

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

Sep 15, 2025, 8:30 AM EDT - 5 months ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Jul 31, 2025, 9:19 PM EDT - 6 months ago

OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 4:05 PM EDT - 6 months ago

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

Jun 30, 2025, 8:01 AM EDT - 7 months ago

NextPlat Issues Interim CEO Update Shareholder Letter

NXPL

Jun 25, 2025, 11:00 AM EDT - 7 months ago

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

May 15, 2025, 8:00 AM EDT - 9 months ago

OPKO Health to Participate in Two Upcoming Investor Conferences

Apr 30, 2025, 7:52 PM EDT - 9 months ago

OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript

Apr 4, 2025, 8:00 AM EDT - 10 months ago

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

Mar 17, 2025, 8:57 AM EDT - 11 months ago

OPKO and Entera partner to develop obesity pill

Mar 11, 2025, 7:00 AM EDT - 11 months ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Feb 27, 2025, 7:12 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:10 PM EST - 1 year ago

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

Jan 9, 2025, 11:45 AM EST - 1 year ago

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 18, 2024, 8:00 AM EST - 1 year ago

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

NXPL

Nov 14, 2024, 6:00 AM EST - 1 year ago

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

BABA NXPL

Nov 7, 2024, 8:30 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript

Oct 7, 2024, 8:00 AM EDT - 1 year ago

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Oct 7, 2024, 8:00 AM EDT - 1 year ago

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

NXPL

Sep 16, 2024, 7:30 AM EDT - 1 year ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Aug 7, 2024, 4:06 PM EDT - 1 year ago

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

Jul 17, 2024, 4:14 PM EDT - 1 year ago

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments

May 31, 2024, 10:48 AM EDT - 1 year ago

OPKO Health to Participate in the Jefferies Global Healthcare Conference

May 7, 2024, 8:03 PM EDT - 1 year ago

OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

May 3, 2024, 8:00 AM EDT - 1 year ago

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 28, 2024, 8:00 AM EDT - 2 years ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Mar 5, 2024, 8:52 AM EST - 2 years ago

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

Feb 27, 2024, 8:08 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 2 years ago

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Feb 22, 2024, 4:05 PM EST - 2 years ago

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

Jan 9, 2024, 4:05 PM EST - 2 years ago

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes

Jan 4, 2024, 11:31 PM EST - 2 years ago

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

Jan 3, 2024, 5:05 PM EST - 2 years ago

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

Nov 28, 2023, 7:00 AM EST - 2 years ago

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

Nov 7, 2023, 6:45 AM EST - 2 years ago

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

SOPH

Nov 6, 2023, 7:32 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 4:05 PM EST - 2 years ago

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

Nov 2, 2023, 10:00 AM EDT - 2 years ago

New Clinical Data on OPKO Health's RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Oct 31, 2023, 8:00 AM EDT - 2 years ago

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Oct 25, 2023, 4:25 PM EDT - 2 years ago

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

Oct 20, 2023, 1:30 PM EDT - 2 years ago

OPKO Health: FDA Approval To Save The Company

Sep 28, 2023, 4:08 PM EDT - 2 years ago

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

Aug 4, 2023, 12:17 AM EDT - 2 years ago

OPKO Health, Inc. (OPK) Q2 2023 Earnings Call Transcript

tymtested Feb. 2 at 10:24 PM

$OPK The huge volume is a mystery.

1 · Reply

Mike18181 Feb. 2 at 8:57 PM

0 · Reply

Mike18181 Feb. 2 at 7:22 PM

$OPK Not undervalued ! Its Undermanaged!

0 · Reply

allybaba40t Feb. 1 at 6:40 PM

$OPK and PLTR Have The Same Equity Summary Score, [6.1]... UNBELIEVABLE!!!

1 · Reply

Mike18181 Feb. 1 at 2:55 PM

$OPK Zehorney (Opko President) will broadcast upcoming Q1 2026 shareholder address from a " gas station mens room " as he boards another plane. Nice job Pal ! Were still losing Money Sweety !@

0 · Reply

Sierradude Jan. 30 at 5:21 PM

$OPK Will be interesting to see what the old coot does with his shares when he croaks....

1 · Reply

Zerrat Jan. 30 at 3:48 PM

$OPK stock buy back and year low. Such a joke

0 · Reply

Mike18181 Jan. 30 at 12:43 AM

$OPK Plenty of cash on hand , and this stock is an absolute bargin.🤡🛌🤡 🛌 🤡 🛌 🤡 is poised to to rocket up to a price of 1.35 this year ! Buy rating from many Blind brokers

0 · Reply

magadog Jan. 29 at 8:41 AM

$OPK newcomers see this as too cheap until the Frost factor kicks in.. He loves penny stocks so much he turned he whole company into a penny stock

0 · Reply

Biotechguy21 Jan. 28 at 11:42 PM

$OPK ceo in jail yet? ?????

1 · Reply

Brasil07 Jan. 27 at 4:45 PM

$OPK I only Hope that something or someone put the end to this agony....

1 · Reply

tymtested Jan. 27 at 1:39 PM

$OPK https://seekingalpha.com/article/4862813-opko-health-deeply-mispriced-ahead-of-major-catalysts?mailingid=43746868&messageid=2800&position=rta_analysis_popular_main_3_textlink&serial=43746868.2493&source=email_2800&utm_campaign=rta-stock-article&utm_medium=email&utm_source=seeking_alpha&utm_term=43746868.2493

0 · Reply

tymtested Jan. 27 at 1:32 PM

$OPK

2 · Reply

tymtested Jan. 27 at 1:18 PM

$OPK

0 · Reply

magadog Jan. 27 at 12:56 PM

$OPK Sounds mean... Frost has very infrequently used the Shareholder word and he has done some pretty snakey moves I'm guessing you're correct. I doubt he has 2-4 years left. His ego seems to terrify the BOD. The next CC should creep this a bit higher and if there are signals he shopping this, maybe we could see $3 or $4.. The AI monster will propel Pharma's ahead however this mess is old school and Frost is not very cognitively active . As far as screwing the shareholders, no doubt they wouldn't hesitate for a second.

0 · Reply

Mike18181 Jan. 27 at 11:52 AM

$OPK Facts : Negative free cashflow ( Major financial drainage) - 2.8 Accumulated deficits / since 2006 startup * Impossible to retain any cash, want more Facts - EPS negative even with one time gains. Cash on hand , open your eyes !!! Sale of assets to convert to cash, but not from operations. Stock buy back, is in p l axe to keep it over 1.00 buck. Great company run by Frost !

0 · Reply

Mike18181 Jan. 26 at 4:29 PM

$OPK Smart money is Smart ! They avoid companies that cant retain cash, lose money Eps report over repirt, and broken guidance ! Its 1 31 because the truth is transperant of the reality.. Buy back stock, and shares are dumped.

0 · Reply

Indyshaw Jan. 25 at 12:04 PM

$OPK $REGN

1 · Reply

tymtested Jan. 25 at 1:54 AM

$OPK 90% of all daily trades are algorithmic and based on stock technicals with no connection to underlying business fundamentals. Don t believe it? Do a fact check and google it !

1 · Reply

TommyCotton Jan. 24 at 2:15 AM

$OPK I hear some “Frost must go” and I’ve been there. But now, that becomes precarious. Frost has a lot of skin in the game and ego. When he’s gone that leaves with him and job one for a board will be to get the share price over $5-$10. The way the board will do that is dump the loss on the current share holders and reverse split the stock. It’s an easy way out. When that happens your investment will ultimately be lost.

0 · Reply

Brasil07 Jan. 23 at 7:19 PM

$OPK It's Simply : Frosty must die!

1 · Reply

LongAllDay Jan. 23 at 7:15 PM

$OPK FROST must be curing insomnia cause this thing is a SNORE FEST

0 · Reply

Market Cap	967.30M
Revenue (ttm)	713.14M
Net Income (ttm)	-53.22M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-7.46%
Debt to Equity Ratio	0.19

Volume	2,056,700
Avg Vol	3,498,518
Day's Range	N/A - N/A
Shares Out	767.70M
Stochastic %K	11%
Beta	1.39
Analysts	Strong Sell
Price Target	$2.57